Similac Alimentum vs Puramino - Cross-Manufacturer eHF to AAF Step-Up (Abbott eHF vs Reckitt AAF)

Similac Alimentum is Abbott's extensively hydrolyzed casein formula for diagnosed CMPA, first-line for ~90% of CMPA infants. Puramino is Reckitt's amino acid formula, the escalation tier when eHF fails or when severe indications are documented. Comparing them cross-manufacturer reflects the clinical pathway some families walk when moving from Alimentum to AAF and their pediatric team prefers the Reckitt AAF (Puramino) over Abbott's AAF (EleCare). Understanding the logic helps families advocate for the right escalation.

Why this comparison matters

When a CMPA infant escalates from Alimentum (eHF) to AAF, most go to EleCare (Abbott's intra-manufacturer escalation, covered in our Alimentum vs EleCare comparison). Some families go cross-manufacturer to Puramino (Reckitt AAF), typically because: (a) Puramino's GOS prebiotic fits the clinical preference for microbiome support, (b) Reckitt Zeeland distribution works better locally than Sturgis-sourced EleCare, (c) pediatric GI or allergist prefers Reckitt's AAF, (d) post-2022 Sturgis recall concerns, some families cross to the Reckitt facility. This cross-manufacturer path is less common but clinically legitimate when indicated.

The CMPA management ladder: cross-manufacturer view

Alimentum sits at step 3 (Abbott side). Puramino sits at step 4 (Reckitt side). Moving Alimentum → Puramino is two tiers of escalation plus a manufacturer crossover, a clinically significant move, not a minor SKU swap.

At a glance

* Maltodextrin (Alimentum) and corn syrup solids (Puramino) are medically appropriate in CMPA / severe-allergy context.

Visual generated with Napkin AI, editorial review by María López Botín. See methodology for our use policy.

Compositional differences that actually matter

1. Protein: hydrolyzed peptides vs free amino acids

Alimentum: extensively hydrolyzed casein (<3,000 Da) and free amino acids supplementation. Most CMPA infants tolerate this because the peptides are too small for immune recognition. ~10% remain reactive to even tiny peptides.

Puramino: 100% free amino acids, individual monomers. Non- antigenic. The most hypoallergenic commercially available. For infants who fail eHF, amino-acid composition eliminates the remaining antigenic potential.

2. Indication: CMPA first-line vs escalation / severe

Alimentum: first-line eHF for diagnosed CMPA. Most CMPA infants respond within 2-4 weeks.

Puramino: indicated for:

• eHF trial failure (Alimentum or Nutramigen) at 2-4 and weeks
• Severe CMPA presentations
• Multiple food protein allergy
• Eosinophilic esophagitis (EoE) / eosinophilic GI disease
• Short-gut syndrome / severe malabsorption
• Failure to thrive secondary to food allergy

3. Bioactive strategy: 2'-FL HMO (Alimentum) vs GOS prebiotic (Puramino)

Alimentum includes 2'-FL HMO, the first and only eHF in the US market with HMO inclusion. Positioning: bioactive microbiome support in the CMPA context.

Puramino includes GOS prebiotic (galacto-oligosaccharide) + PDX (polydextrose). Positioning: synthetic prebiotic supporting microbiome in the severe-allergy AAF context.

For parents escalating from Alimentum → Puramino, you lose 2'-FL HMO but gain GOS. Different bioactive mechanisms. Neither is definitively superior; both support microbiome but through different pathways (HMO = human milk oligosaccharide; GOS = synthetic galacto-oligosaccharide that similarly supports Bifidobacterium genera). For parents specifically valuing HMO in CMPA context and escalating to AAF, EleCare is not the better choice (no HMO, no prebiotic): Puramino's GOS or Neocate Syneo's full synbiotic are the AAF tiers with bioactive additions.

4. Fat blend: both palm-free and MCT (rare continuity)

Both Alimentum, Puramino use palm-free, and MCT fat blends. This is a shared strength, the fat composition continuity between Alimentum and Puramino is better than between Alimentum and EleCare (which is also palm-free and MCT, but stripped of other additions) or between Nutramigen and EleCare (which is palm-inclusive → palm-free, a larger fat-composition change).

For families whose infant is doing well on Alimentum's palm-free and MCT but needs AAF escalation, Puramino's identical fat archetype makes the transition easier than cross-manufacturer alternatives. This is an underrated advantage of the Alimentum → Puramino pathway.

5. Primary carbohydrate: maltodextrin vs corn-syrup-solids

Alimentum (powder): maltodextrin primary and sucrose secondary. Medically appropriate for CMPA.

Puramino: corn syrup solids primary and GOS secondary. Medically appropriate for severe-allergy AAF.

Both are lactose-free. Maltodextrin has slightly lower glycemic response than corn syrup solids, but the practical difference in this clinical context is minimal.

6. Price: Puramino ~21% more expensive per-oz

Alimentum ~$4.55/oz. Puramino ~$5.50/oz. ~21% price premium for the AAF tier.

Compared to the Alimentum → EleCare path (~43% premium), the Alimentum → Puramino path is less expensive per-oz, because Puramino's Reckitt Zeeland production has different cost structure than EleCare's Sturgis sole-source positioning.

US private insurance and Medicaid typically cover both AAFs with pediatrician letter of medical necessity documenting CMPA and eHF failure or severe indication.

7. Availability: both AAF-distribution-pattern (pharmacy-ordered)

Alimentum is broadly available at US major retail. Puramino is typically pharmacy-ordered or specialty-distributor-ordered — Target/Walmart rarely stock it in standard shelving. This is similar to EleCare distribution; AAFs uniformly have pharmacy-order patterns.

8. Recall history

Alimentum (Abbott): affected by the 2022 Cronobacter recall at Sturgis (among the Sturgis SKUs). Abbott remediated Sturgis; Alimentum production resumed; current stock passes FDA inspection.

Puramino (Reckitt Zeeland): no active Puramino-specific recall. Reckitt Zeeland had the December 2023 Cronobacter event affecting Nutramigen Powder specifically; Puramino was not directly affected. Reckitt implemented enhanced testing at the facility.

For families weighing the Abbott 2022 recall context in escalation choice: Puramino's Reckitt Zeeland production is a facility-switch that some families view positively. Abbott's Sturgis current FDA compliance is stable; the historical event is legitimate family context but not a current safety red flag.

When to cross-manufacturer from Alimentum to Puramino

Typical clinical triggers for Alimentum → Puramino specifically (vs Alimentum → EleCare, which is the more common Abbott-internal escalation):

• eHF trial failure on Alimentum with pediatric team preferring GOS prebiotic in the AAF tier
• Distribution, local pharmacy stocks Puramino but not EleCare
• Insurance formulary favors Puramino
• Post-2022 Sturgis recall context where family prefers Reckitt Zeeland facility
• Pediatric GI or allergist specifically prefers Reckitt AAF
• Desire for bioactive AAF: Puramino's GOS is preferable to EleCare's stripped composition for some families

Discuss with pediatric team. Don't self-escalate AAF or cross manufacturers without clinical guidance.

Real-world parent experience

Following site methodology, observations come from US parent feedback. Not clinical recommendations. Where my own feeding observations are referenced, they are clearly labeled as parent-experience notes; manufacturer claims and regulatory data are cited separately so the source weight stays explicit.

Transition ease (relatively). Alimentum → Puramino is one of the easier eHF → AAF transitions in their ingredients because both are palm-free and MCT. The protein change (peptides → free amino acids) is still significant, and taste shifts (Puramino is more bitter than Alimentum, which has 2'-FL HMO sweetness), but the fat blend continuity reduces stool pattern disruption that fat-blend changes can produce. Plan 7-10 day gradual transition; some families manage 5-7 days successfully.

Taste and smell. Alimentum has a slightly sweeter profile (2'-FL HMO adds mild sweetness). Puramino is more bitter (free amino acids). Most infants initially resist the transition; 3-7 days gradual adjustment typical. If severe aversion, pediatric team may approve small amounts of rice cereal flavoring (for older infants

4-6 months); don't add flavorings without guidance.

Stool consistency. Alimentum's HMO and 2'-FL contribution typically produces slightly softer/looser stool. Puramino's GOS contribution also softens stool through Bifidobacterium fermentation. Stool consistency continuity is better than a transition to EleCare (no prebiotic, can firm up).

Weight gain. Both provide adequate calories. Puramino's elevated 28% protein is designed to compensate for amino-acid metabolic differences. Monitor growth during transition.

Verdict: when this cross-manufacturer pathway applies

Stay on Alimentum if:

• New CMPA diagnosis or ongoing stable CMPA management
• Responding well to Alimentum (no escalation needed)
• Value 2'-FL HMO bioactive contribution

Escalate to Puramino if:

• Pediatric team has documented eHF trial failure or specific severe indication
• Reckitt AAF pathway preferred over EleCare (distribution, insurance, GOS prebiotic inclusion)
• Fat blend continuity matters (both palm-free and MCT = easier transition)

Pick neither if:

• Not diagnosed CMPA, neither is appropriate
• Intra-Abbott escalation preferred, consider EleCare (Abbott AAF, stripped composition)
• AAF and synbiotic preferred, consider Neocate Syneo (Nutricia AAF with both prebiotic and probiotic)
• First-line Reckitt eHF alternative, consider Nutramigen (eHF, Reckitt, with LGG probiotic)

What you can't infer from this comparison

This is a clinical escalation decision, not a composition preference. The Alimentum → Puramino path is legitimate when clinically indicated; it's inappropriate if Alimentum is working. Puramino isn't universally "better" than Alimentum, it's a different tier. Starting with Puramino when Alimentum would have sufficed provides no clinical benefit. If your pediatrician prefers EleCare, that's the more common intra-Abbott escalation; Puramino is the cross-manufacturer alternative when specific factors favor Reckitt AAF.

Frequently asked questions

Related reading

• Similac / Alimentum brand hub
• Puramino brand hub
• Nutramigen vs Puramino, intra-Reckitt eHF → AAF
• Similac Alimentum vs EleCare, intra-Abbott eHF → AAF
• Nutramigen vs EleCare, cross-manufacturer Reckitt eHF → Abbott AAF
• Nutramigen vs Similac Alimentum, cross-manufacturer eHF head-to-head
• CMPA and formula
• Abbott 2022 recall aftermath
• Hydrolyzed casein explainer
• Amino acid formulas explainer
• GOS explainer
• 2'-FL HMO explainer
• Neocate Syneo vs EleCare - AAF with Synbiotic vs AAF Stripped (Nutricia vs Abbott)
• Neocate Syneo vs Puramino - Two Bioactive Amino Acid Formulas Head-to-Head (Nutricia Synbiotic vs Reckitt Prebiotic)

Primary sources

1. Similac Alimentum / Abbott Nutrition, manufacturer product information. similac.com
2. Puramino Infant / Reckitt (Mead Johnson), manufacturer product information. puraminoinfant.com
3. FDA 21 CFR Part 107 (incl. 107.30 exempt infant formula). ecfr.gov
4. FDA infant formula guidance documents. fda.gov
5. FDA Abbott recall investigation summary (2022). fda.gov
6. ESPGHAN position on CMPA management: Koletzko et al., JPGN.

This site provides research and comparisons, not medical advice. Consult your pediatrician before changing your baby's formula.